| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.33 | 0.01 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.4 | 0.01 |